All regulatory conditions have been fulfilled. The transaction, which was announced on March 20, 2025, and approved by Xbrane’s Extraordinary General Meeti REYKJAVIK, Iceland, June 02 ...

Alvotech (NASDAQ: ALVO, ALVO-SDB), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has completed its transaction with Xbrane ...

Amidst a backdrop of renewed uncertainty about U.S. trade policy and escalating geopolitical tensions in the Middle East, European markets have seen declines, with the pan-European STOXX Europe 600 ...

Amid renewed uncertainty about U.S. trade policy and escalating geopolitical tensions in the Middle East, European markets have seen a decline, with the pan-European STOXX Europe 600 Index ending 1.57 ...

The European market has recently faced challenges, with the pan-European STOXX Europe 600 Index dropping by 1.57% amid renewed uncertainty surrounding U.S. trade policy and escalating geopolitical ...

OneSource Specialty Pharma, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2109.35. The stock has experienced fluctuations today ...

Press Release on subscription of equity shares of Xbrane Biopharma AB Sweden Quant Small Cap Fund - Direct (G) 321.06 16,70,468 1.14 Quant Small Cap Fund - Direct (IDCW) 321.06 16,70,468 1.14 Motilal ...